Prognosis of patients who relapse after fertility-sparing surgery in epithelial ovarian cancer

Annals of Surgical Oncology

Volumn 15, Issue 2, 2008, Pages 478-483

  Marpeau, Olivier ^a   Schilder, Jeanne ^b   Zafrani, Yaelle ^a   Uzan, Catherine ^a   Gouy, Sebastien ^a   Lhommé, Catherine ^a   Morice, Philippe ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Conservative surgery; Outcomes; Ovarian cancer; Prognosis; Recurrence

Indexed keywords

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FERTILITY SPARING SURGERY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY CANCER; PROGNOSIS; SURGICAL TECHNIQUE; CANCER STAGING; EPITHELIUM CELL; MORTALITY; OVARY TUMOR; PATHOLOGY; PATIENT SELECTION; PERITONEUM TUMOR; SURVIVAL; TUMOR RECURRENCE;

ADULT; EPITHELIAL CELLS; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PATIENT SELECTION; PERITONEAL NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 40649095274     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9651-x     Document Type: Article

References (16)

1. DiSaia PJ. Conservative management of the patient with early gynecologic cancer. CA Cancer J Clin 1989; 39:135-54
2. Colombo N, Chiari S, Maggioni A, Bocciolone L, Torri V, Mangioni C. Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol Oncol 1994; 55:S47-S51
3. Zanetta G, Chiari S, Rota S, Bratina G, Maneo A, Torri V, Mangioni C. Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol 1997; 104:1030-5
4. Schilder JM, Thompson AM, DePriest PD, et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol 2002; 87:1-7
5. Morice P, Camatte S, Wicart-Poque F, et al. Results of conservative treatment in epithelial ovarian carcinoma. Cancer 2001; 92:2412-8
6. Brown C, Hyman J, Almadrones L, et al. Conservative surgical management of early epithelial ovarian cancer. Proc ASCO 1995; 14:766
7. th Biennal Meeting of the International Gynecologic Cancer Society. October 20-24, 2002, Seoul. Int J Gynecol Cancer 2002; 5:519
8. Raspagliesi F, Fontanelli R, Paladini D, Di Re EM. Conservative surgery in high-risk epithelial ovarian carcinoma. J Am Coll Surg 1997; 185:457-60
9. Morice P, Wicart-Poque F, Rey A, et al. Conservative treatment of epithelial ovarian Cancer: Results of a French multicenter study of the GCCLCC (Groupe des Chirurgiens de Centres de Lutte Contre le Cancer) and SFOG (Societe Française d'Oncologie Gynécologique). Human Reprod 2005; 20:1379-85
10. Colombo N, Parma G, Lapresa MT, Maggi F, Piantanida P, Maggioni A. Role of conservative surgery in ovarian cancer: the European experience. Int J Gynecol Cancer 2005; 15 Suppl 3:206-11
11. International Federation of Gynecology and Obstetrics. Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 1987; 156:263-4
12. Morice P, Joulie F, Camatte S, et al. Lymph node involvement in epithelial ovarian cancer: Analysis of 276 pelvic and para-aortic lymphadenectomies and surgical implications. J Am Coll Surg 2003; 197:198-205
13. Vergote I, De Brabanter J, Fyles A, et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001; 357:176-82
14. Ahmed FY, Wiltshaw E, A'Hern RP, et al. Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol 1996; 14:2968-75
15. Dembo AJ, Davy M, Stenwig AE, Berle EJ, Bush RS, Kjorstad K. Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1990; 75:263-73
16. Moore MM, Tewari K, Rose GS, Frauehauf JP, Di Saia PJ. Long-term consequences following conservative management of epithelial ovarian cancer in an infertile patient. Gynecol Oncol 1999; 73:452-4